Finance

Lists
Outlook: 13.0% bullish·21.7% bearish
Go to analysis
LULU:NASDAQ
Lululemon Athletica Inc
$93.68
+1.08%
(+1.00) 1D
Oct 9, 1:28:51 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LULU...
Open
$92.88
High
$94.62
Low
$91.67
Mkt. cap
10.37B
Avg. vol.
7.14M
Volume
1.53M
P/E ratio
7.68
52-wk high
$225.93
52-wk low
$90.38
EPS
$12.20
Beta
0.92
Shares outstanding
105.59M
No. of employees
39K
Open
$92.88
High
$94.62
Low
$91.67
Mkt. cap
10.37B
Avg. vol.
7.14M
Volume
1.53M
P/E ratio
7.68
52-wk high
$225.93
52-wk low
$90.38
EPS
$12.20
Beta
0.92
Shares outstanding
105.59M
No. of employees
39K
News stories
From web sources and news partners
Profile
Lululemon, commonly styled as lululemon, is a Canadian-American multinational athletic apparel retailer headquartered in Vancouver, British Columbia, and incorporated in Delaware, United States, as Lululemon Athletica Inc. It was founded in 1998 as a retailer of yoga pants and other yoga wear, and has expanded to also sell sportswear, lifestyle apparel, shoes, accessories and personal care products. The company has 811 stores and also processes sales online through its website. Wikipedia
About Lululemon Athletica Inc
CEOHeidi O'Neill
Employees39K
Founded1998
HeadquartersVancouver, British Columbia, Canada
SectorLuxury goods
Websitecorporate.lululemon.com
Analyst ratings
Based on 26 analysts giving stock ratings to LULU in the past 3 months
Hold
Buy
1
Hold
21
Sell
4
12-month forecast
Based on 26 Wall Street analysts offering 12 month price targets for LULU in the last 3 months.
Highest
Current $93.68
$169.00 (+80.39%)
Average
$101.05 (+7.86%)
Lowest
$44.00 (-53.03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Peter McGoldrick
Stifel Nicolaus
Hold
Reiterated
$100.00
+6.7%
10/08/2026
Alexandra Straton
Morgan Stanley
Sell
Maintained
$83.00
-11.4%
10/07/2026
Robert Drbul
BTIG
Hold
Maintained
-
-
10/07/2026
Ike Boruchow
Wells Fargo
Hold
Maintained
$95.00
+1.4%
09/28/2026
Brooke Roach
Goldman Sachs
Hold
Maintained
$95.00
+1.4%
09/14/2026
Christine Dooley
Argus Research
Hold
Maintained
-
-
09/11/2026
Matthew Boss
J.P. Morgan
Hold
Maintained
$95.00
+1.4%
09/09/2026
Sharon Zackfia
William Blair
Hold
Maintained
-
-
09/09/2026
Paul Lejuez
Citi
Hold
Maintained
$117.00
+24.9%
09/10/2026
Kelly Crago
BMO Capital
Sell
Initiated
$70.00
-25.3%
09/09/2026
Unknown Analyst
BMO Capital
Sell
Initiated
$70.00
-25.3%
09/09/2026
Aneesha Sherman
Bernstein
Hold
Maintained
$115.00
+22.8%
09/08/2026
Adrienne Yih
Barclays
Hold
Maintained
$95.00
+1.4%
09/08/2026
Zachary Warring
CFRA
Buy
Maintained
$169.00
+80.4%
09/04/2026
Simeon Siegel
Guggenheim
Hold
Maintained
-
-
09/04/2026
Dana Telsey
Telsey Advisory
Hold
Maintained
$110.00
+17.4%
09/04/2026
Krisztina Katai
Deutsche Bank
Hold
Reiterated
$98.00
+4.6%
09/04/2026
Laurent Vasilescu
Exane BNP Paribas
Sell
Maintained
$44.00
-53%
09/04/2026
Joseph Civello
Truist Financial
Sell
Reiterated
$82.00
-12.5%
09/04/2026
Mark Altschwager
Robert W. Baird
Hold
Maintained
$115.00
+22.8%
09/04/2026
Anna Andreeva
Piper Sandler
Hold
Maintained
$80.00
-14.6%
09/04/2026
Jay Sole
UBS
Hold
Maintained
$106.00
+13.1%
09/04/2026
Tom Nikic
Needham
Hold
Reiterated
-
-
09/04/2026
Ashley Owens
KeyBanc
Hold
Maintained
-
-
09/04/2026
Lorraine Hutchinson
Bank of America Securities
Hold
Maintained
$122.00
+30.2%
09/04/2026
Janine Stichter
BTIG
Hold
Reiterated
-
-
09/04/2026
Michael Binetti
Evercore ISI
Hold
Maintained
$115.00
+22.8%
09/02/2026
Randal Konik
Jefferies
Hold
Maintained
$115.00
+22.8%
09/01/2026
Georgy Vashchenko
Freedom Capital Markets
Hold
Upgraded
$139.00
+48.4%
06/05/2026
Angus Kelleher-Ferguson
Barclays
Hold
Reiterated
$161.00
+71.9%
04/22/2026
Last report
Sep 3, 2026
Fiscal period
Q2 2027
$2.06 / $1.80
+14.67%beat
Revenue / Est. (USD)
2.42B / 2.46B
-1.77%miss
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Nov 2025
Feb 2026
May 2026
Aug 2026
Revenue
2.57B
3.64B
2.47B
2.42B
Cost of goods sold
1.14B
1.64B
1.13B
1.09B
Cost of revenue
1.14B
1.64B
1.13B
1.09B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
988.25M
1.18B
1.06B
1.01B
Operating expense
990.03M
1.19B
1.06B
1.01B
Total operating expenses
2.13B
2.83B
2.19B
2.10B
Operating income
435.89M
812.29M
276.95M
319.15M
Other non operating income
5.85M
975.00K
9.13M
9.60M
EBT including unusual items
441.74M
813.26M
286.08M
467.35M
EBT excluding unusual items
441.74M
813.26M
286.08M
332.85M
Income tax expense
134.90M
226.39M
91.03M
138.13M
Effective tax rate
30.54%
27.84%
31.82%
29.56%
Other operating expenses
-
-
-
-
Net income
306.84M
586.87M
195.05M
329.22M
Net profit margin
11.96%
16.12%
7.89%
13.63%
Earnings per share
2.59
5.01
1.69
2.06
Interest and investment income
-
-
-
4.10M
Interest expense
-
-
-
-
Net interest expenses
-
-
-
4.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
563.34M
946.82M
412.28M
461.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps